Telix QSAM, Inc

QSAM Biosciences, Inc. is a pioneering biotech company based in Austin, TX, dedicated to revolutionizing cancer treatment through the development and delivery of targeted therapeutic radiopharmaceuticals. Their lead product, CycloSam, is a clinical-stage bone-seeking radiopharmaceutical that delivers controlled doses of radiation directly to tumors in the bone, with the aim of halting or regressing primary and metastatic tumors in both children and adults.

With a commitment to addressing unmet medical needs and underserved patient populations, QSAM Biosciences is focused on developing a pipeline of novel radiotherapeutics to serve multiple indications, including metastatic bone cancers, pediatric osteosarcoma, Ewing's sarcoma, and bone marrow ablation. Their patented improvements to increase efficacy and utility, reduce toxicity, and streamline production make CycloSam a promising next-generation treatment option in the fight against cancer.

Generated from the website